OGN.NYSEOrganon & CO

Form 4: Organon GC Weaver Boosts Stake via PSU Vesting

Sentiment:

Statement of Changes in Beneficial Ownership


Organon & Co.'s General Counsel, Kirke Weaver, increased beneficial ownership of common stock through the vesting of performance share units and dividend equivalents.

Summary

  • Kirke Weaver, General Counsel & Corporate Secretary of Organon & Co. (OGN), reported changes in beneficial ownership of common stock.
  • On February 27, 2026, 21,925 shares of common stock were acquired due to the release of performance share units (PSUs) granted on August 11, 2023, following certification of performance goal attainment.
  • An additional 6,186 shares of common stock were acquired on February 27, 2026, representing dividend equivalents earned on the released PSUs.
  • A disposition of 6,815 shares of common stock occurred on February 27, 2026, at a price of $7.17 per share, likely to cover tax withholding obligations.
  • Another disposition of 1,763 shares of common stock occurred on February 27, 2026, at a price of $7.23 per share, also likely for tax withholding.
  • The reported beneficial ownership includes an addition of 1,832.163 shares of common stock from dividend equivalents not previously required to be reported.
  • Following these transactions, Kirke Weaver beneficially owns 73,854.163 shares of Organon & Co. common stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as slightly positive. The vesting of performance share units indicates the company met specific performance goals, which is a positive signal, and the increase in insider ownership aligns management's interests with shareholders.

Positives

  • The vesting of 21,925 performance share units indicates that Organon & Co. met specific performance goals, as certified by the Talent Committee of the Board of Directors.
  • The acquisition of shares through PSU vesting and dividend equivalents increases the General Counsel's direct ownership in the company, aligning management's interests with those of shareholders.

Negatives

  • Disposition of 6,815 shares at $7.17 and 1,763 shares at $7.23 for tax withholding is a standard practice for equity compensation and not inherently negative.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

StockSavvy.ai notes that routine insider transactions like the vesting of performance share units and subsequent tax-related sales are common across industries for executive compensation. These events reflect the standard operation of long-term incentive plans designed to align executive interests with shareholder value.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Power of AttorneyKirke Weaver granted a Power of Attorney to Tarnetta V. Jones and Faye C. Brown to execute and file Forms 3, 4, and 5 on his behalf, manage his EDGAR account, and perform related actions.07/27/2025This streamlines the process for fulfilling SEC reporting obligations for the reporting person, ensuring timely and accurate filings.

Related Party Transactions

  • The transactions involve the acquisition of shares by an officer (Kirke Weaver) from Organon & Co. as part of an equity compensation plan (PSUs and dividend equivalents), which are standard related-party dealings for executive compensation.

Stakeholder Impact

  • Shareholders: The vesting of performance share units suggests the company achieved certain performance targets, which is generally positive for shareholders. Increased insider ownership also aligns management's incentives with shareholder value creation.

Key Dates

DateDescription
08/11/2023Grant date of performance share units (PSUs) to Kirke Weaver.
07/27/2025Date of the Power of Attorney granted by Kirke Weaver for SEC filings.
02/27/2026Transaction date for the acquisition of common stock from PSU vesting and dividend equivalents, and disposition of shares for tax withholding.
03/03/2026Signature date of the Form 4 filing.

Recommendation

hold

This Form 4 details routine executive compensation events (PSU vesting and tax-related sales) for Organon & Co.'s General Counsel. While the vesting indicates performance goals were met, these transactions are standard and do not provide new fundamental information to warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate as this filing alone does not present a compelling reason to buy or sell.

Keywords

Organon, OGN, Kirke Weaver, Form 4, insider trading, beneficial ownership, performance share units, PSUs, equity compensation, General Counsel

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.